BUZZ-Amgen up after quarterly results beat Wall Street estimates
I'm PortAI, I can summarize articles.
Shares of Amgenrose 1.7% to $343.99 in after-hours trading following a strong quarterly performance. The company reported a 9% increase in revenue to $9.9 billion, surpassing analyst expectations of $9.5 billion. Adjusted earnings per share for Q4 were $5.29, exceeding the forecast of $4.73. Amgen anticipates adjusted earnings per share of $21.60 to $23.00 for 2026, with annual revenue projected between $37 billion and $38.4 billion, above the $37.1 billion estimate from analysts. The stock has increased by 3.5% in 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments